Regulatory considerations on authorization of the use of convalescent plasma (PC) to address the COVID-19 emergency, 22 April 2020
Fecha
2020Número de documento
PAHO/IMS/COVID-19/20-0008
Metadatos
Mostrar el registro completo del ítemResumen
Since the last century, passive immunization has been used for the prevention and treatment of some human infectious diseases. The serum of convalescent patients is the treatment of choice in cases of Argentine Hemorrhagic Fever. In addition, it was use during outbreaks of Ebola in Africa and also during the SARS and MERS outbreaks, as no other therapeutic options existed. Experience to date with the use of convalescent plasma for the treatment of COVID-19 is limited, but preliminary results indicate potential usefulness. Several controlled clinical trials are underway, to collect more quality scientific evidence to confirm the safety and efficacy of this intervention. In this context, the recommendations foresee its use under experimental conditions within the regulatory framework of each country. Moreover, there are challenges for large-scale collection, processing, and distribution of plasma from convalescent patients to meet potential clinical needs. Some published guidance exists for the collection and use of plasma from convalescent patients in infectious disease cases and Ebola outbreaks and even in the current COVID-19 situation.
Tema
Colecciones
Esta leyenda debe conservarse, junto con la URL original del artículo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (PAHOUnited StatesWashington, D.C., 2020)COVID-19 treatment options currently under study include several antiviral drugs and immune modulators, the antimalarials chloroquine and hydroxychloroquine, corticosteroids, convalescent plasma, pharmaceutical products ...
-
Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (PAHOUnited StatesWashington, D.C., 2020)This document includes the results of a rapid systematic review of currently available literature. The information included in this review reflects the evidence as of the date posted in the document. Yet, recognizing that ...
-
Organización Panamericana de la Salud (2021)[RESUMEN]. Introducción. La Organización Mundial de la Salud declaró en el 2020 la pandemia de la enfermedad por el coronavirus 2019 (COVID-19, por su sigla en inglés), causada por el coronavirus de tipo del síndrome ...